Taro Shareholders Approve Merger with Sun Pharma
Taro’s shareholders have approved the merger agreement with Sun Pharma, as announced by the Mumbai-based pharmaceutical giant on Thursday. The approval came during an extraordinary general meeting and an ordinary class meeting on May 22, 2024. Dilip Shanghvi, Managing Director of Sun Pharma, expressed satisfaction with the shareholders’ approval. “We are pleased with the approval…
